evaluating

PawPro GmbH Set to Transform Pet Health and Web3: Opens Pre-Seed Investment Round

Source Node:
Time Stamp: September 18, 2024 11:03 AM - Modified On: September 18, 2024 - Published By:
Source Cluster:
Republished By Plato

  Singapore, September 2024 — PawPro GmbH, a leading German PetTech startup specializing in advanced pet healthcare solutions, is excited to announce its Pre-Seed investment round. This round offers investors the opportunity to join PawPro as it revolutionizes the pet health industry through innovative products and cutting-edge Web3 technology. Innovative Pet Healthcare Solutions PawPro’s groundbreaking bacteria-based supplements are redefining pet health. Our formulas, enhanced with nano-technology, include probiotics, Omega-3, and Bacillus Subtilis, which was named the Microbe of the Year 2023 by the Association for General and Applied Microbiology (VAAM).

EarthID Sets New Standard in Decentralized Identity Management

Source Node:
Time Stamp: February 13, 2024 10:25 AM - Modified On: February 13, 2024 - Published By:
Source Cluster:
Republished By Plato

[London, Feb 13, 2024] — EarthID has been assessed by the Government Blockchain Association’s (GBA) Blockchain Maturity Model (BMM), earning a Maturity Level One rating. ‘’We are thrilled to have earned GBA's BMM rating. This achievement is more than a milestone; it's a reflection of our unwavering commitment to providing secure, user-centric identity solutions whilst meeting the demanding requirements of enterprise clients.’’ stated Priya Guliani, EarthID’s CEO. EarthID is a decentralized identity platform, enabling organizations to safeguard and minimize personally identifiable customer data, prevent identity fraud, while empowering users with

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

The Government Blockchain Association (GBA) Publishes Blockchain Maturity Model (BMM) Overview Document

Source Node:
Time Stamp: January 17, 2023 10:41 AM - Modified On: January 17, 2023 - Published By:
Source Cluster:
Republished By Plato

Washington, DC - January 17, 2023 - The Government Blockchain Association (GBA) is pleased to announce the publication of the Blockchain Maturity Model (BMM) Overview Document. It is available for download at https://gbaglobal.org/wp-content/uploads/2023/01/01-Blockchain-Matuirity-Model-Overview-v1.0-2.pdf, and provides an in-depth look at the content, structure, use, and maintenance of the GBA BMM. The BMM is a comprehensive framework that includes requirements, resources, and tools applicable to blockchain solutions. A blockchain solution includes all layers (network, protocol, application, and transactions) of the solution. The model is designed to assist government organizations in evaluating and improving their blockchain capabilities. "We are